Cancer. It’s a word no woman wants to hear. But one in three women will be diagnosed with cancer in her lifetime. In Illinois, more than 11,000 women are projected to be diagnosed with breast cancer and about 3,500 with a gynecologic cancer in 2021. Cancer, especially those unique to women, may pose physical and emotional challenges. The disease may develop in your breasts or your reproductive organs, creating challenges and concerns about fertility, sexual health and self-image.
At Cancer Treatment Centers of America® (CTCA), Chicago, we understand the unique nature of cancers that are unique to women. That’s why we created the Women’s Cancer Center at CTCA® Chicago. Our experienced doctors and clinicians are singularly focused on screening, diagnosing and treating breast cancer and gynecologic cancers with a sense of urgency. Our supportive care services are designed to help address symptoms and side effects, to help you have the strength and stamina to continue your treatment and the quality of life to help you continue everyday activities throughout your cancer journey.
Why wait? The Women’s Cancer Center can schedule your appointment in as little as 24 hours. Treatments may begin within 48 hours of your first visit, and some appointments may be available via telehealth using the CTCA Anywhere videoconferencing technology. Call us or chat online.
Available 24/7 to discuss treatment options
The Women’s Cancer Center can schedule your appointment in as little as 24 hours.
Treatments may begin within 48 hours of your first visit.
At the Women’s Cancer Center at CTCA Chicago, your multidisciplinary team of doctors and clinicians works together every day to deliver the care you need and the care you deserve. We offer cancer screenings, diagnostic evaluations, treatments plans, survivorship and supportive care services, all under one roof.
Concerned about COVID-19? We're taking extraordinary measures to protect our patients, caregivers and employees from the COVID-19 virus.
Some cancers in women may be caused by genetic mutations inherited from past generations. Some of these mutations are associated with inherited cancer syndromes that may increase your risk of developing specific cancers, including breast cancer.
The High-Risk Breast Cancer Screening Program at CTCA Chicago offers genetic testing that may find inherited mutations, while our genetic counselors will help interpret test results and develop strategies designed to reduce your cancer risk.
An early and accurate diagnosis is often the key to developing a treatment plan designed to produce positive outcomes. At the Women’s Cancer Center at CTCA Chicago, we use sophisticated techniques and advanced diagnostic tools, such as 3D mammography, designed to give you and your oncologists the information needed to make informed decisions about your care.
Diagnostic tools used at the Women’s Cancer Center include a variety of imaging tests, including sentinel lymph node biopsy, mammography and lab tests that may help detect abnormal cells or tumor markers.
Advances in cancer treatment have made multiple options available for women with breast cancer and gynecologic malignancies. The cancer experts at the Women’s Cancer Center at CTCA Chicago offer a wide variety of standard-of-care, minimally invasive and innovative treatment options, including:
The cancer journey doesn’t always end when treatments are over—especially for patients diagnosed with cancers unique to women. Breast cancer and gynecologic cancers and their treatments often have symptoms and side effects that may affect your sexual wellness and fertility, while also causing pain or mobility issues, changes to your physical appearance and impacts on your emotional and mental state.
Your care team at the Women’s Cancer Center at CTCA Chicago will collaborate with a team of supportive care clinicians to explore medical and supportive care options, including:
Behavioral health, offering mental health services to support you before, during and after treatment.
The Women’s Cancer Center at CTCA Chicago also offers DigniCap®, a therapy cleared by the U.S. Food and Drug Administration to help reduce hair loss during chemotherapy.
"The day of my surgery, I was a nervous but confident about choosing CTCA. I arrived at CTCA and began to prep for my surgery. The various nurses and doctors came in to greet me and made sure I knew their role during surgery. CTCA was so accommodating and encouraging to us. We never felt rushed. They allowed my support system to make me feel comfortable before I had to go in for surgery. It was clear that I also had a dedicated team of doctors and clinicians who were there to support me. "
New patients: 866-318-0135
Existing patients: 847-510-CTCA
Donate to Gateway for Cancer Research
Make a difference in the fight against cancer by donating to cancer research
Gateway for Cancer Research is a 501(c)(3) non-profit organization. Tax-ID: 73-1386920
